Early Screening Key to Reducing Lung Cancer Deaths
Radiation oncologist Dr. Andrea McKee believes deaths from lung cancer — including those related to asbestos exposure — could be reduced significantly by increased utilization of early CT screening. McKee, chair of radiation oncology at Lahey Hospital and Medical Center in Burlington, Maine, has been a strong proponent of early screening for several years. “We could be saving tens of thousands of lives every year with this,” McKee told The Mesothelioma Center at Asbestos.com. “There is nothing else like it. The life-saving potential is the most important thing that has happened to cancer in my...
Source: Asbestos and Mesothelioma News - December 4, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Study Shows Cancer Patients Can Benefit from Opioid Switching
Switching from one prescription opioid to another often solves the problem of debilitating side effects or inadequate pain relief, according to a recent study involving a wide range of cancer patients. Opioids are not all the same. And neither are those they are helping. Despite the increasing government restrictions and the frenzy over potential abuse, opioids can be a lifesaver for a mesothelioma patient finding the right fit. “I’ve been through both sides of that switching issue,” said Tim Crisler, a 16-year pleural mesothelioma survivor told The Mesothelioma Center at Asbestos.com. “It worked gr...
Source: Asbestos and Mesothelioma News - November 26, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Abramson Developing CAR T-Cell Therapy for Mesothelioma
The National Cancer Institute awarded a five-year, $10.7 million grant to the Abramson Cancer Center at the University of Pennsylvania to develop CAR T-cell therapy for mesothelioma and lung cancer. The hopes are high for a breakthrough. The program involves a laboratory modification of a patient’s T cells — a type of white blood cell — that prompts the immune system to attack cancer cells. The therapy also is known as chimeric antigen receptor T-cell therapy. It already is revolutionizing the way some blood and bone marrow cancers are treated. The grant is designed to investigate whether this type of gen...
Source: Asbestos and Mesothelioma News - November 20, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

New jury fails to reach verdict in J & J South Carolina talc cancer trial
A second South Carolina jury on Thursday failed to reach a verdict in the retrial of a case by a woman whose family said her long-term use of Johnson& Johnson's baby powder led to her death from asbestos-related cancer. (Source: Reuters: Health)
Source: Reuters: Health - November 16, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Jury clears J & J of liability in California talc cancer case
A California jury on Wednesday cleared Johnson& Johnson of liability in a case involving a woman who alleged that the company's talc-based products, including its baby powder, contain asbestos and caused her cancer, the company said. (Source: Reuters: Health)
Source: Reuters: Health - November 14, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Mesothelioma Patients Can Benefit from Genetic Testing
All patients diagnosed with malignant mesothelioma should undergo genetic testing to better identify the most appropriate treatment plan, according to Dr. Michele Carbone, the director of thoracic oncology at the University of Hawaii Cancer Center. Genetic testing also could lead to a more accurate prognosis and help family members determine if they are more susceptible to the cancer. Carbone estimates only one-third of all mesothelioma patients today have undergone the testing. “Some of these patients could definitely benefit from genetic testing,” Carbone told The Mesothelioma Center at Asbestos.com. Carbon...
Source: Asbestos and Mesothelioma News - November 13, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Department of Justice Looking Closer at Asbestos Trusts
The U.S. Department of Justice has increased its scrutiny of asbestos trust funds in recent months, urging more accountability and transparency. Those who administer the funds believe they work just fine. The trust funds are designed mostly to compensate workers who were sickened by negligent companies that sold or manufactured asbestos products. Currently there are more than 60 trust funds with an estimated $30 billion combined, stemming from companies seeking bankruptcy protection and avoiding future liabilities related to asbestos exposure. Since the first trust was established in 1988, they have paid out more than $20 ...
Source: Asbestos and Mesothelioma News - November 7, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Alimta-Related Skin Reactions with and Without Oral Steroids
This study supports the use of intravenous dexamethasone 10 mg before pemetrexed infusion in place of three days of oral dexamethasone 4 mg twice daily at UNMCCC,” the authors wrote. The post Alimta-Related Skin Reactions with and Without Oral Steroids appeared first on Mesothelioma Center - Vital Services for Cancer Patients & Families. (Source: Asbestos and Mesothelioma News)
Source: Asbestos and Mesothelioma News - November 5, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Radiation Could Make Mesothelioma Immunotherapy More Effective
Doctors at the Princess Margaret Cancer Center in Toronto are studying the use of hypofractionated radiation to increase the effectiveness of immunotherapy for patients with mesothelioma. They are expected to launch soon a clinical trial that will add an immunotherapy combination to the high-dose radiation and aggressive surgery mix that has been so successful in Toronto. “There are a lot of questions that still need to be answered, but if I was a betting man, I’d lay odds on it [working well],” Dr. John Cho of the cancer center’s clinical research unit, told The Mesothelioma Center at Asbestos.com....
Source: Asbestos and Mesothelioma News - November 2, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

French Study Reveals Potential Mesothelioma Treatment Target
A team of French researchers led by Dr. Christophe Blanquart has identified a substance that may better define the severity of malignant pleural mesothelioma (MPM) in the body and provide clues to more effectively manage the rare cancer. Brain-derived neurotrophic factor, as the name indicates, is a protein found in the brain. BDNF is a growth factor and also appears in other tissues in the body. “It seems that BDNF could be a prognostic marker for MPM patients,” Blanquart told The Mesothelioma Center at Asbestos.com. “The level of BDNF in pleural fluids could reflect the severity of disease.” The...
Source: Asbestos and Mesothelioma News - October 31, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

US steps up scrutiny of funds for asbestos exposure victims
The Trump administration has stepped up scrutiny of trust funds for victims of asbestos exposure (Source: ABC News: Health)
Source: ABC News: Health - October 31, 2018 Category: Consumer Health News Tags: Health Source Type: news

The Guardian view on misinformation: a moral problem | Editorial
Those seeking to deceive politicians and the public know distraction works better than outright fraudMost of the recent worries over the spread of propaganda have concentrated on the use of social media: WhatsApp, Facebook, Twitter and YouTube have all beenrightly criticised for their use in spreading misinformation. Less attention, perhaps, has been given to the content of the messages and the strategy behind their use. The template for many modern campaigns of disinformation was invented by the tobacco industry as it fought against the mounting evidence that it was selling a product that killed its users.The “tobac...
Source: Guardian Unlimited Science - October 26, 2018 Category: Science Authors: Editorial Tags: Science Journalism, publishing and public relations Climate change Tobacco industry Source Type: news

NovoCure slides on Q3 sales miss
NovoCure (NSDQ:NVCR) shares took a hit today, despite lower-than-forecast losses, after the company reported financial results that missed expectations for third-quarter sales. Losses were up 1.7% to -$11.7 million, or -13¢ per share, on sales growth of 29.2% to $64.8 million for the three months ended Sept. 30, compared with Q3 2017. The consensus estimate on Wall Street was for losses of -15¢ on sales of $65.4 million. “We delivered record quarterly revenue of $64.8 million in the third quarter, representing 5% quarter-over-quarter growth, driven by both active patient growth and ongoing improve...
Source: Mass Device - October 25, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Drug-Device Combinations MassDevice Earnings Roundup Wall Street Beat NovoCure Source Type: news

Pioneering UK nursing post created for asbestos-related cancer
Samantha Westbrook has been appointed as the first peritoneal mesothelioma clinical nurse specialist in the UK. (Source: Nursing Times)
Source: Nursing Times - October 25, 2018 Category: Nursing Source Type: news

U.S. Asbestos Imports Surge in August, Report Finds
The amount of raw chrysotile asbestos imported into the United States increased significantly between July and August, according to a recent analysis from the Asbestos Disease Awareness Organization and the Environmental Working Group. The U.S. International Trade Commission and Department of Commerce provided the two advocacy organizations the data for their report. According to the investigation, the U.S. imported 272 metric tons (approximately 600,000 pounds) of asbestos in August — an increase of nearly 2,000 percent from the 13 metric tons in July. EWG and ADAO on Tuesday attributed the alarming spike to the g...
Source: Asbestos and Mesothelioma News - October 24, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Mesothelioma Early Detection Getting Closer with Blood Test
German scientists are advancing a new, more reliable blood test that could lead to earlier detection and better prognosis for malignant mesothelioma. Instead of the typically lengthy and invasive process, the simple blood test could identify early stage disease almost a year before symptoms appear, making it much more treatable. The advancement stems from a study analyzing a combination of calretinin and mesothelin, two blood-based proteins that are overexpressed when mesothelioma tumors start growing. “This is a real breakthrough,” biochemist Dr. Georg Johnen, lead study researcher and head of Molecular Medici...
Source: Asbestos and Mesothelioma News - October 23, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Penn researchers land $10.7M grant to study CAR-T cell therapy in solid tumors
The University of Pennsylvania's Abramson Cancer Center had received a $10.7 million grant from the National Cancer Institute to study CAR-T cells in solid tumors The five-year grant from the NCI's will support new experimental approaches in lung cancer and mesothelioma being conducted by Penn researchers at its translational center of excellence for lung cancer immunology “Although CAR-T cells have been revolutionized the treatment of leukemia and bone marrow cancers, we have not yet had the… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - October 22, 2018 Category: American Health Authors: John George Source Type: news

Penn researchers land $10.7M grant to study CAR-T cell therapy in solid tumors
The University of Pennsylvania's Abramson Cancer Center had received a $10.7 million grant from the National Cancer Institute to study CAR-T cells in solid tumors The five-year grant from the NCI's will support new experimental approaches in lung cancer and mesothelioma being conducted by Penn researchers at its translational center of excellence for lung cancer immunology “Although CAR-T cells have been revolutionized the treatment of leukemia and bone marrow cancers, we have not yet had the… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 22, 2018 Category: Biotechnology Authors: John George Source Type: news

Canada Announces Ban of Asbestos, But with Exemptions
The Canadian government released the final draft last week of its much-anticipated ban on asbestos, making it illegal to import, manufacture, sell, trade or use products made with the toxic mineral. The ban, which goes into effect Dec. 30, 2018, contains exemptions that still allow its use in the chlor-alkali industry, the military, nuclear facilities and for magnesium extraction from asbestos mining residue. It will be known as The Prohibition of Asbestos and Products Containing Asbestos Regulations. Canadian Environment Minister Catherine McKenna touted the tough new regulations during the announcement, but critics stil...
Source: Asbestos and Mesothelioma News - October 22, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Canada Announces Asbestos Ban with Exemptions
The Canadian government released the final draft last week of its much-anticipated ban on asbestos, making it illegal to import, manufacture, sell, trade or use products made with the toxic mineral. The ban, which goes into effect Dec. 30, 2018, contains exemptions that still allow its use in the chlor-alkali industry, the military, nuclear facilities and for magnesium extraction from asbestos mining residue. It will be known as The Prohibition of Asbestos and Products Containing Asbestos Regulations. Canadian Environment Minister Catherine McKenna touted the tough new regulations during the announcement, but critics stil...
Source: Asbestos and Mesothelioma News - October 22, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Study Highlights Surgery Benefits of P/D over EPP for Mesothelioma
This study focused on 30-day mortality and postoperative complications. It included a meta-analysis of 39 previous studies from 1990 to 2017, along with the New York Statewide Planning and Research Cooperative System database from 1995 to 2012. Study results included: 30 Day Mortality: EPP 5 percent; P/D 2 percent Postoperative Complications: EPP 46 percent; P/D 24 percent Postoperative Arrhythmias: EPP 20 percent; P/D 5 percent. Although there is no cure for pleural mesothelioma, aggressive surgery — with either the P/D or EPP — has been proven to extend survival times. According to a recent study pub...
Source: Asbestos and Mesothelioma News - October 19, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

New federal asbestos ban includes controversial exemptions
New regulations designed to ban asbestos will go into effect by the end of this year, however an analysis of the final rules introduced Wednesday reveals they have been watered down from what the federal government originally proposed. (Source: CBC | Health)
Source: CBC | Health - October 18, 2018 Category: Consumer Health News Tags: News/Politics Source Type: news

UK Study Matches Mesothelioma Treatments to Genetic Profile
University of Leicester researchers soon will open the first molecularly stratified clinical trial for malignant mesothelioma with the hope of moving the future of treatment toward more personalization. The phase II trial in the United Kingdom is designed to match therapy with a patient’s specific genetic profile. “We’re trying to bring the right drug to the right patient at the right time,” Professor Dean Fennell, chair of thoracic medical oncology at Leicester and chief trial investigator, told Asbestos.com. “We need to find different treatments that work for different people. This is a step...
Source: Asbestos and Mesothelioma News - October 12, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Jury clears J & J of liability in New Jersey talc cancer case
A New Jersey jury on Thursday cleared Johnson& Johnson of liability in a case involving a woman who alleged that the company's talc-based products, including its baby powder, contain asbestos and caused her cancer. (Source: Reuters: Health)
Source: Reuters: Health - October 11, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Asbestos Case Among First for Kavanaugh in Supreme Court
The U.S. Supreme Court on Wednesday will hear a product liability case filed by widows of Navy sailors seeking to recover damages for injuries related to asbestos exposure. It will be the third case on the docket for Justice Brett Kavanaugh, who was sworn in Saturday by Chief Justice John Roberts and retiring Justice Anthony Kennedy. The asbestos case, Air and Liquid Systems Corp. v. DeVries, involves a group of Navy sailors who developed mesothelioma from asbestos exposure. Defendants include Air & Liquid Systems and other large companies that manufactured equipment used by the Navy. Key facts about the case: Eq...
Source: Asbestos and Mesothelioma News - October 10, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Brooklyn Opens Its Mesothelioma Specialty Center
Mesothelioma patients from Brooklyn won’t need to travel far from home anymore to receive specialized care for this rare and aggressive cancer. The Brooklyn Mesothelioma Center has opened. Maimonides Medical Center is the top cancer facility in Brooklyn. It has been treating mesothelioma patients for many years, but the arrival of thoracic surgeon Dr. Ory Wiesel has taken its program to another level. “We can provide the care now that these patients, before, maybe went elsewhere to find,” Wiesel told Asbestos.com. “We’re creating a dedicated mesothelioma program, with the expertise necessary, ...
Source: Asbestos and Mesothelioma News - October 8, 2018 Category: Environmental Health Authors: Daniel King Source Type: news

Review Highlights Better Targets for Mesothelioma Therapy
A review on targeted therapies for malignant pleural mesothelioma (MPM) provides fresh insight into why this cancer is so difficult to treat and ideas for improving outcomes. “Despite more than two decades of intensive research on the possible treatments for MPM, the results have so far been disappointing,” the authors wrote. According to the in-depth review, published in Critical Reviews in Hematology/Oncology, the next steps toward more tailored mesothelioma treatment will come from learning more about the changes driving abnormal cell communication. Researchers will use this information to personalize treatm...
Source: Asbestos and Mesothelioma News - October 4, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Trust prosecuted for asbestos failings
An NHS trust in the West Midlands is to be prosecuted for asbestos failures by the Health and Safety Executive. (Source: HSJ)
Source: HSJ - October 3, 2018 Category: UK Health Source Type: news

CAR T-Cell Therapy May ‘ Change the Paradigm of Treating Mesothelioma ’
Thoracic surgeon and scientist Dr. Prasad Adusumilli at Memorial Sloan Kettering (MSK) Cancer Center believes customized gene therapy will soon change the way pleural mesothelioma is treated. Adusumilli, director of the Mesothelioma Program at MSK, has worked for a decade on developing tumor immunology for thoracic malignancies. He is currently the principal investigator of a phase I clinical trial involving specially prepared immune cells — chimeric antigen receptor (CAR) T cells — that have shown impressive efficacy with mesothelioma. “I think this is going to change the paradigm of treating mesotheliom...
Source: Asbestos and Mesothelioma News - October 1, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

#MayoClinicRadio podcast: 9/29/18
Listen: Mayo Clinic Radio 9/29/18 On this week's Mayo Clinic Radio podcast, Dr. Shanda Blackmon, a thoracic surgeon at Mayo Clinic, explains lung cancer screening and surgical options for treating the disease. Dr. Blackmon also covers?mesothelioma, another type of cancer that often occurs in the tissue surrounding the lungs.?Also on the podcast, Dr. Jamie Van [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 1, 2018 Category: Databases & Libraries Source Type: news

J & J Dodges Verdict in Mesothelioma Trial, Imerys Settles
Johnson & Johnson’s latest trial over claims its iconic baby powder causes mesothelioma ended in mistrial this week after a California jury couldn’t reach a decision in the case of school counselor Carolyn Weirick. Lawyers for Weirick asked jurors for $25 million in compensation for past and future pain and suffering related to her mesothelioma, a rare cancer linked to asbestos exposure. Weirick, 59, was diagnosed with mesothelioma in 2017 and said her only exposure to asbestos came from the use of J&J’s talc-based products for more than 40 years. A state judge in Pasadena, California, declared a ...
Source: Asbestos and Mesothelioma News - September 28, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

International Symposium on Mesothelioma to Focus on Immunotherapy
The eighth annual International Symposium on Malignant Pleural Mesothelioma Saturday at UCLA will reflect the rapidly evolving philosophy on future treatment of this rare cancer. Change is coming. The Symposium, which was first held in 2011 to help bring awareness to lung-sparing surgery, will highlight groundbreaking discoveries and the latest advances in immunotherapy and gene therapy — believed to be the future of cancer care. The longtime chemotherapy and surgery standard-of-care routine is fading. The symposium at the Luskin Conference Center on the UCLA campus in Los Angeles will help explain why. “There ...
Source: Asbestos and Mesothelioma News - September 26, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Lume Meso Phase III Results
Results of LUME-Meso trial in malignant pleural mesothelioma presented at the 19th World Conference on Lung Cancer (WCLC 2018)The primary endpoint of progression-free survival was not met in the Phase III LUME-Meso Trial (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - September 25, 2018 Category: Research Source Type: news

Study: Aggressive Surgery Underutilized with Pleural Mesothelioma
Aggressive surgery for the treatment of malignant pleural mesothelioma is being underutilized, costing patients significant survival time, according to a recent study. Researchers found mesothelioma patients from all three histological subtypes — epithelioid, biphasic and sarcomatoid — can benefit from surgery, despite a reluctance to perform it today. The National Comprehensive Cancer Network (NCCN), a nationwide alliance of leading cancer centers, encourages surgery only for epithelioid patients. This eliminates the option for almost 40 percent of those diagnosed with mesothelioma. “Surgery is underutil...
Source: Asbestos and Mesothelioma News - September 25, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Government Report: EPA Failed to Properly Monitor Asbestos in Schools
A recent report from the Environmental Protection Agency’s internal watchdog shows the agency isn’t doing enough to minimize asbestos risks in U.S. schools. From 2011 through 2015, the EPA conducted only 13 percent of the Asbestos Hazard Emergency Response Act (AHERA) inspections it was responsible for nationwide, according to a report released Monday by the EPA’s Office of Inspector General. States with jurisdiction over their own inspections performed 87 percent, more than six times that of federal implementation jurisdictions. “Our objective was to determine whether the EPA was performing suffici...
Source: Asbestos and Mesothelioma News - September 21, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Enhancing Cancer Immunotherapy with Artificial Intelligence
Physicians may soon use artificial intelligence (AI) and medical images to study tumors without a biopsy. The techniques developed to study tumors in this new way are described in the September 1 issue of The Lancet Oncology. Along with helping physicians learn more about tumors without surgery, the new approach should help identify which cancer patients will respond best to cutting-edge immunotherapy treatments. The AI techniques could be useful for “predicting clinical outcomes of patients treated with immunotherapy when validated by further prospective randomized trials,” the authors wrote. Immunotherapy tre...
Source: Asbestos and Mesothelioma News - September 19, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Novel Mesothelioma Treatment Closer to FDA Approval
Standard-of-care treatment for patients with pleural mesothelioma may soon include Tumor Treating Fields (TTF), a novel therapy involving electric currents that disrupt cancer cell division and inhibit tumor growth. In the wake of recently released results from Novocure’s STELLAR phase II clinical trial, the U.S. Food and Drug Administration (FDA) is expected to approve the treatment within the next six months, giving mesothelioma patients another much-needed option. “At this point, it should be a relatively rapid approval process,” Dr. Eilon Kirson, chief science officer at Novocure, the oncology company...
Source: Asbestos and Mesothelioma News - September 17, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Africa:Worldwide Effects of Asbestos Use
[IPS] Wallingford, Ct, Us -Earlier this summer, the Environmental Protection Agency of the United States (EPA) issued a Significant New Use Rule (SNUR) on asbestos, a naturally occurring mineral that is also a known carcinogen. Asbestos is the only definitive cause of mesothelioma, a cancer which affects the linings of internal organs. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 17, 2018 Category: African Health Source Type: news

Worldwide Effects of Asbestos Use
By Emily WalshWALLINGFORD, CT, US, Sep 14 2018 (IPS)Earlier this summer, the Environmental Protection Agency of the United States (EPA) issued a Significant New Use Rule (SNUR) on asbestos, a naturally occurring mineral that is also a known carcinogen. Asbestos is the only definitive cause of mesothelioma, a cancer which affects the linings of internal organs.What is a Significant New Use Rule?A SNUR can be required when chemical substances or mixtures are under review for new uses that may cause changes to current policy, or create concerns around environmental health. There are four criteria to determine whether a SNUR i...
Source: IPS Inter Press Service - Health - September 14, 2018 Category: International Medicine & Public Health Authors: Emily Walsh Tags: Environment Headlines Health North America Source Type: news

Dr. R. Taylor Ripley Leads Mesothelioma Center at Baylor
Thoracic surgeon Dr. R. Taylor Ripley comes to the Mesothelioma Treatment Center at Baylor College of Medicine with the highest possible endorsement. Dr. David Sugarbaker, the world’s most prominent mesothelioma specialist and director of the prestigious Baylor Lung Institute, recruited Ripley. It was like being anointed by the king. Ripley spent the previous four years at the National Cancer Institute (NCI) in Bethesda, Maryland, where he built a sterling reputation for surgical, clinical and investigational research excellence. “Dr. Sugarbaker wanted someone to help grow his program. He recruited me to do tha...
Source: Asbestos and Mesothelioma News - September 12, 2018 Category: Environmental Health Authors: Daniel King Source Type: news

Ripley Named New Director of Mesothelioma Center at Baylor
Thoracic surgeon Dr. R. Taylor Ripley comes to the Mesothelioma Treatment Center at Baylor College of Medicine with the highest possible endorsement. Dr. David Sugarbaker, the world’s most prominent mesothelioma specialist and former director of the prestigious Baylor Lung Institute, recruited Ripley. It was like being anointed by the king. Ripley spent the previous four years at the National Cancer Institute (NCI) in Bethesda, Maryland, where he built a sterling reputation for surgical, clinical and investigational research excellence. “Dr. Sugarbaker wanted someone to help grow his program. He recruited me to...
Source: Asbestos and Mesothelioma News - September 12, 2018 Category: Environmental Health Authors: Daniel King Source Type: news

Surgery for Mesothelioma No Longer Recommended in UK
Aggressive surgery for the treatment of malignant pleural mesothelioma (MPM) — unless part of a clinical trial — is no longer being recommended in the United Kingdom. The British Thoracic Society recently published its Mesothelioma Management Guidelines for 2018 and removed surgery from its recommendations. The belief was that potential harm was not worth the risk. The backtrack on surgery included the extrapleural pneumonectomy (EPP), the extended pleurectomy and decortication (P/D) and the partial pleurectomy (PP) — all of which are being done at cancer centers in the United States. “Surgery is a ...
Source: Asbestos and Mesothelioma News - September 11, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

9/11 Cancer Deaths Continue to Rise
John Feal believes more people will die from illnesses related to 9/11 than from the terrorist attack at the World Trade Center. He should know. He’s a first responder who witnesses it every day. And he is not alone in his belief. Feal, a longtime advocate for Sept. 11 survivors and those dying from diseases related to the terrorist attacks, will again host the annual naming ceremony at the 9/11 Responders Remembered Park in Smithtown, Long Island. Each year he reads the names of those who have died within the past year. And each year, the list is longer than the last. On the 17th anniversary of the terrorist attack...
Source: Asbestos and Mesothelioma News - September 10, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Nigeria:Lagos Govt Warns Against Use of Asbestos in Homes
[Premium Times] The Lagos State Commissioner for Housing, Gbolahan Lawal, has alerted the public against the use of asbestos as ceiling in homes, saying it could cause cancer. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 10, 2018 Category: African Health Source Type: news

Study links BAP1 protein to tumor suppression in kidney, eye, bile duct and mesothelioma cancers
(University of Texas M. D. Anderson Cancer Center) Researchers at The University of Texas MD Anderson Cancer Center have shown how BRCA-associated protein 1 (BAP1) serves as a tumor suppressor gene in kidney, eye, bile duct, mesothelioma and other cancers by regulating a form of cell death called ferroptosis, opening up a potential new area of therapy research. Findings from the study, led by Boyi Gan, Ph.D., associate professor, Department of Experimental Radiation Oncology, were published in the Sept. 10 online issue of Nature Cell Biology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 10, 2018 Category: Cancer & Oncology Source Type: news

Novocure touts combined TTF, chemotherapy mesothelioma study data
Novocure (NSDQ:NVCR) today released results from the Stellar phase 2 registration trial exploring the use of its Tumor Treating Fields and standard of care chemotherapy to chemotherapy alone in treating mesothelioma, touting a significant extension in median overall survival. Patients with malignant pleural mesothelioma who received TTF treatment alongside pemetrexed and cisplatin or carboplatin experienced a median overall survival of 18.2 months, compared to 12.1 months in a historical control, the St. Helier, Jersey-based company said. Read the whole story on our sister site, Drug Delivery Business News The post No...
Source: Mass Device - September 6, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Drug-Device Combinations Oncology NovoCure Source Type: news

Mother claims 'hugging her father' may have led to her devastating cancer diagnosis
Kate Richmond, from Victoria's  Mornington Peninsula, was diagnosed with peritoneal mesothelioma - a rare cancer, caused by exposure to asbestos. (Source: the Mail online | Health)
Source: the Mail online | Health - September 6, 2018 Category: Consumer Health News Source Type: news

Alternative Cancer Treatment Clinic Reopening in Bahamas
Jerry Lampe and Ruth Phillips — two of America’s longest-living mesothelioma survivors — won’t feel so helpless now when a newly diagnosed patient asks for their secret to success. The controversial Immune Augmentation Therapy (IAT) Clinic in Freeport, Bahamas, is set to reopen in October, giving mesothelioma patients a proven, alternative therapy option once again. IAT operated outside of U.S. regulation from 1977 to 2016. The name has been changed to Quantum Immunologics, but the philosophy surrounding cancer treatment is exactly the same, a throwback to when Lampe and Phillips were treated origi...
Source: Asbestos and Mesothelioma News - September 5, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Girl, 14, becomes 'one of the youngest people in the world' to have asbestos-related cancer
Macie Greening, from Cullompton in Devon, has undergone four rounds of chemotherapy to tackle her peritoneal mesothelioma - but to no avail. (Source: the Mail online | Health)
Source: the Mail online | Health - September 4, 2018 Category: Consumer Health News Source Type: news